MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the sale of
common stock and...
$14,931,536
Proceeds from exercise of
common stock warrants
$601,914
Net cash provided by
financing activities
$15,533,450
Net increase
(decrease) in cash and cash...
$594,339
Canceled cashflow
$14,939,111
Loss from change in
fair value of...
$6,743,736
Loss (gain) from
change in fair value of...
$2,791,813
Accounts receivable
-$1,376,322
Stock-based compensation
$881,150
Loss on equity method
investment
-$38,634
Amortization
$30,074
Net cash used in
operating activities
-$14,939,111
Canceled cashflow
$11,861,729
Net (loss) income
-$23,058,135
Accounts payable
-$2,873,739
Prepaid expenses and
other current assets
$439,855
Accrued expenses
-$295,952
Inventory
$119,660
Operating lease
liabilities
-$13,499
Back
Back
Cash Flow
source: myfinsight.com
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK)